{"version":"1.0","provider_name":"Brakke\u54a8\u8be2\u7f51\u7ad9","provider_url":"https:\/\/brakkeconsulting.com\/zh","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Q3aXxChTFe\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/23504\/\">2002\u5e743\u67081\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u7b80\u62a5<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/zh\/23504\/embed\/#?secret=Q3aXxChTFe\" width=\"600\" height=\"338\" title=\"\u300a Animal Health News &#038; Notes for March 1, 2002 \u300b\u2014Brakke Consulting Website\" data-secret=\"Q3aXxChTFe\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for March 1, 2002 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company Earnings Releases &nbsp; &gt;&nbsp; Embrex announced fourth-quarter revenues for 2001 were $11.6 million, an increase of 15% over the same period in 2000. Fourth-quarter net income was $1.9 million, an increase of 4% over net income of $1.8 million for the same period in 2000, after a write-off of $0.2 million of unamortized leasehold improvements. Sales of Bursaplex in ovo bursal disease vaccine were up 43% over the fourth quarter of 2000, contributing to the revenue increase.&nbsp; For the year ended December 31, 2001, revenues were $44.7 million, a 15% increase over revenues of $38.8 million during the same period of 2000.&nbsp; Net income for the full-year 2001 rose 20% to $8.0 million from $6.6 million for the full-year 2000. (company website) &gt;&nbsp; OurPet&rsquo;s Company released financial results for the fourth quarter and year ended December 31, 2001. Fourth quarter sales were $1.56 million versus $1.83 million in the year-earlier period. Net income for the quarter was $77,295 versus $181,325 in the fourth quarter of 2000. For the full year, sales totaled $5.51 million, an increase of 5.9% over 2000 yearly sales of $5.21 million. 2001 net income of $93,770 compared to a loss of ($144,844). In the year 2001, OurPetView Full Post;"}